A detailed history of Schroder Investment Management Group transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 48,099 shares of CLDX stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,099
Previous 48,099 -0.0%
Holding current value
$1.19 Million
Previous $1.78 Million 8.26%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$22.61 - $40.65 $1.09 Million - $1.96 Million
48,099 New
48,099 $1.91 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.16B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.